Dr. Ryanne Wu recently returned to Duke after three years in Singapore.
NEW YORK (GenomeWeb) – Duke University spinout Predigen Diagnostics is developing a multiplex platform that uses host gene expression signatures as
The Rhodes Scholarship is one of the most prestigious awards granted to college students, with recipients selected on the basis of high academic achievement, personal integrity, leadership potential and a commitment to service.
The Duke CTSA TL1 physician fellowship provides 2 years of funded time to support the research training of physician-scientists. We have particula
Every day, we dispose of valuable information about our health without even thinking about it.
Deadline: February 15, 2019
The Enabling Precision Health and Medicine Bass Connections team, led by Susanne Haga has been renewed for the 2019-2020 school year.
A new Bass Connections project, the Smart Toilet: A disruptive technology to improve health and wellness, led by Geoff Ginsburg, has been funded for the 2019-2020 school year.
Ephraim Tsalik is one of five finalists for the Antimicrobial Resistance Diagnostic Challenge through NIH. He will receive a grant to further develop his prototype and supply it for testing to two CLIA-certified independent laboratories.
Micah McClain received a 4-year Merit Award from the VA to explore the host genomic response to rickettsial infections in human patients and develop novel PCR-based tests that are capable of accurately diagnosing Spotted Fever Group rickettsii and Scrub typhus infections, which will allow for better therapeutic decision making.
Geoff Ginsburg was part of a team that investigated the US landscape of research programs in PGx implementation, reviewed current advances and clinical applications of PGx, summarized the obstacles that have hindered PGx implementation, and identified the critical knowledge gaps and possible studies needed to help to address them.
Ginsburg co-authored an overview of precision medicine and its vital stakeholders. Haga along with Duke undergraduate research assistant Ariel Kantor report on their analysis of the number and types of pharmacogenetic tests offered by clinical testing laboratories in the U.S.
Led by researchers from Harvard Medical School and Harvard Pilgrim Health Care Institute, the study reported variation between Medicare contractors and private insurers regarding coverage of testing for cancer treatment.
Several CAGPM staff and faculty co-authored a paper published in Genetics in Medicine on implementation, adoption, and utility of family health history risk assessment in diverse care settings.
Rachel Mills and several other genetic counselors have published examples of pharmacogenetic testing applications across a range of medical specialties.
Deepak Voora, Susanne Haga and others evaluated the impact of pharmacogenetic testing-informed statin treatment compared to usual care with respect to patient adherence and LDL response.
The CGSU provides the infrastructure and operational excellence to support translational research in genome and implementation sciences.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.